MedPath
NMPA Approval

Loncastuximab Tesirine For Injection

国药准字SJ20240046

December 6, 2024

Drug Information

注射用替朗妥昔单抗

泽路泰

注射剂

10mg/瓶

生物制品

December 6, 2024

December 5, 2029

Company Information

Applicant Company

ADC Therapeutics

Route de la Corniche 3B, Epalinges, Vaud 1066 SWITZERLAND

Manufacturing Company

Via Appia Km 65,561, Latina Scalo, Latina 04013, ITALY

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用替朗妥昔单抗 - NMPA 批准文号 | MedPath